Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.
about
ADHD medications and risk of serious cardiovascular events in young and middle-aged adults.Psychological and pharmacological interventions for depression in patients with coronary artery diseasePsychological and pharmacological interventions for depression in patients with coronary artery diseaseRaised cardiac troponinsImplications of troponin testing in clinical medicineBeckman Access versus the Bayer ACS:180 and the Abbott AxSYM cardiac Troponin-I real-time immunoassays: an observational prospective studyA new scoring system to stratify risk in unstable anginaClinical investigation: thyroid function test abnormalities in cardiac arrest associated with acute coronary syndrome.Does contrast echocardiography induce increases in markers of myocardial necrosis, inflammation and oxidative stress suggesting myocardial injury?Ultrasound imaging versus morphopathology in cardiovascular diseases. Myocardial cell damage.Diagnostic algorithms for acute coronary syndrome-is one better than another?The clinics of acute coronary syndromeCell Therapy in Ischemic Heart Disease: Interventions That Modulate Cardiac RegenerationThe Danish National Patient Registry: a review of content, data quality, and research potentialChallenges of ascertaining national trends in the incidence of coronary heart disease in the United StatesRedefining myocardial infarction: what is new in the ESC/ACCF/AHA/WHF Third Universal Definition of myocardial infarction?Microengineering in cardiovascular research: new developments and translational applications.Risks and complications of coronary angiography: a comprehensive reviewStem cell mechanisms during left ventricular remodeling post-myocardial infarction: Repair and regenerationComparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarctionCardiac troponin and C-reactive protein for predicting all-cause and cardiovascular mortality in patients with chronic kidney disease: a meta-analysis.Impact of a cardiac risk reduction program in vulnerable patients hospitalized with coronary artery diseaseTrends in the care of patients with acute myocardial infarction at a university-affiliated Veterans Affairs Medical CenterElevated troponin and myocardial infarction in the intensive care unit: a prospective study.Long term clinical outcome and bleeding complications among hospital survivors with acute coronary syndromesDetected troponin elevation is associated with high early mortality after lung resection for cancerImproved but still high short- and long-term mortality rates after myocardial infarction in patients with diabetes mellitus: a time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care AdmissionIschaemic symptoms, quality of care and mortality during myocardial infarctionAre patients with non-ST elevation myocardial infarction undertreated?3.0 T cardiovascular magnetic resonance in patients treated with coronary stenting for myocardial infarction: evaluation of short term safety and image qualityOne-year health status outcomes of unstable angina versus myocardial infarction: a prospective, observational cohort study of ACS survivorsDetermination of the threshold of cardiac troponin I associated with an adverse postoperative outcome after cardiac surgery: a comparative study between coronary artery bypass graft, valve surgery, and combined cardiac surgeryCardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxibThe association between a nutritional quality index and risk of chronic diseaseGlycogen phosphorylase BB in acute coronary syndromesHigh-sensitivity cardiac troponin-I is elevated in patients with rheumatoid arthritis, independent of cardiovascular risk factors and inflammationPrognostic significance of elevated cardiac troponin-T levels in acute respiratory distress syndrome patientsDeterminants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database studyA PPARα promoter variant impairs ERR-dependent transactivation and decreases mortality after acute coronary ischemia in patients with diabetesGenome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease.
P2860
Q22253017-5B5417A7-E7C4-42EC-91E3-95174606D7FBQ24234331-D2BACAA2-B162-4539-B618-0D7673AC4B60Q24234618-CF1A7912-7C32-4F68-9A72-3848CA30E422Q24561524-19DB1D42-705D-458F-B60B-6EEE4E51A754Q24793067-9B246A2F-7A9B-44E4-A5BB-CD0D44B05470Q24794734-5C518377-B0F3-4B4F-9833-0C94A5B40648Q24799274-64A7A013-69AF-470D-87F3-D797761B9F93Q24810663-A9883983-3325-40FA-82D3-D5E7483E33F7Q24813805-48D00251-EF1C-477B-9E8D-D515137064EFQ24815286-6590C04E-1B88-436A-8688-1F57764C662AQ26746722-7B4E44F5-F257-4789-BC40-85446A0FF55CQ26746739-5527466C-12CF-4347-9FAB-B0AD97849B5AQ26765916-ED9AC6A3-D0F1-4285-8E4D-9AF4A7A66F68Q26775834-F9153091-EA21-4947-B9F2-663B0A9207C3Q26861748-C49C0AC1-A3E4-46A3-A8ED-3FADD37F0AA5Q27013677-F16B35C8-D7CC-49C6-8430-90A01505A3BFQ27015747-E254E64D-F459-484C-A10C-6F10828A01E3Q27025085-6957BFCE-6F87-45D1-AA68-2CA3707B58B8Q27026285-1F0EAA56-402A-41EF-A814-70E801FA0F3EQ27318070-BDABCC36-5D88-440E-B5E5-EDA0FD865E0EQ27687888-636F87D6-1542-4710-81BB-D19A9DFE9C04Q28169132-2C5B8A93-C349-4B32-B8C7-ECA2C645204CQ28174000-D362907F-3362-4C0B-AE30-EAC6EF2E780FQ28193296-A1F952C1-33B5-4C82-947F-FFA1FA40EC7CQ28195530-AA6C264D-AA28-4B50-9822-697448AA227FQ28200946-351B52FE-6CF5-4B65-86EA-0991F484C7DCQ28217902-9C0057FF-6FA5-4AF0-87D5-336F6F479619Q28218595-E708F520-9A8E-48B3-8E2F-85A630812436Q28219991-8932E814-CDC1-4235-99E2-CF235F55674AQ28221170-59E27866-7966-42C8-943C-A69C55945D90Q28221394-B9303BC9-65C2-4006-9BA1-01CB7D67D8A0Q28222018-99F1D8F6-6C36-4A4B-B13C-CC13EA63C1D9Q28222097-0E9B21E0-9C3D-481C-A6AD-A16D53003439Q28235649-476E1BC6-88A8-4467-A019-A86CB36D176EQ28283661-04C224A3-4857-495F-B961-7D90A78AB6E6Q28480869-0846DD28-D71E-464F-AD57-7A48A184C177Q28481296-C57B2304-08EC-4959-97CA-910E48512E67Q28732420-510F2EE2-449D-4F11-A823-D08F6F19D58EQ28749469-321D8F15-6DBF-4C0E-B971-35D1D5036AC0Q29416988-75D6AF0C-46E5-43DD-B96A-27483A34BB82
P2860
Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Myocardial infarction redefine ...... tion of myocardial infarction.
@ast
Myocardial infarction redefine ...... tion of myocardial infarction.
@en
type
label
Myocardial infarction redefine ...... tion of myocardial infarction.
@ast
Myocardial infarction redefine ...... tion of myocardial infarction.
@en
prefLabel
Myocardial infarction redefine ...... tion of myocardial infarction.
@ast
Myocardial infarction redefine ...... tion of myocardial infarction.
@en
P2093
P1476
Myocardial infarction redefine ...... tion of myocardial infarction.
@en
P2093
P304
P356
10.1016/S0735-1097(00)00804-4
P407
P577
2000-09-01T00:00:00Z